ENLIVEN THERAPEUTICS INC (ELVN)
US29337E1029 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to ELVN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 35.02. This target is 108.7% above the current price.
ELVN was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ELVN.
In the previous month the buy percentage consensus was at a similar level.
ELVN was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-09 | Mizuho | Initiate | Buy |
| 2023-03-29 | Jefferies | Initiate | Buy |
| 2023-03-03 | TD Cowen | Initiate | Outperform |